HIV-1 Specific T -Cells (HST-NEETs) for HIV-Infected Individuals

Summary

This is a phase I, multi-site, study of the safety, immunologic and virologic responses of ex vivo expanded HIV-1 multi-antigen specific T-cell therapy (HST-NEET) as a therapeutic strategy in HIV-infected individuals suppressed on antiretroviral therapy (ART).

Timeline

Start

2019-03-21

Primary completion

2021-09-15

Completion

2022-06-21

Drugs

Indications